Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-28

Clinical Trial Update: Can Pregabalin Reduce the Frequency and Severity of Dry Eye Symptoms After Laser-assisted in Situ Keratomileusis? [Phase 2, Phase 3]

View source ↗

Summary

A randomized trial investigating pregabalin to reduce frequency and severity of dry eye symptoms following LASIK; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: University of Miami | Conditions: Dry Eye | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-08-28